1,337 results match your criteria: "Dyskeratosis Congenita"
Int J Ophthalmol
December 2024
Department of Ophthalmology, the Affiliated Hospital of Yunnan University, Kunming 650000, Yunnan Province, China.
JMIR Form Res
December 2024
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, United States.
Background: Web-based information and social support are commonly used in rare disease communities where geographic dispersion and limited provider expertise complicate in-person support. We examined web-based resource use among caregivers of individuals with telomere biology disorders (TBDs), which are rare genetic conditions with long diagnostic odysseys and uncertain prognoses including multiorgan system cancer risk.
Objective: This study explored internet-based information-seeking and social support practices and perspectives of patients with TBDs and their caregivers.
Ann Med Surg (Lond)
December 2024
University of Health Sciences, Adana Faculty of Medicine, Adana City Education and Research Hospital, Department of Pediatric Hematology and Oncology, Adana, Turkey.
Introduction And Importance: Dyskeratosis congenita (DC) is a rare multisystem disorder primarily characterized by bone marrow failure due to telomere shortening. Typical clinical features include oral leukoplakia, skin hyperpigmentation, and nail dystrophy, along with an increased risk of malignancies. Hoyeraal-Hreidarsson syndrome (HH), a severe variant of DC, is associated with profound neurological and immunological complications, emphasizing the importance of early diagnosis and genetic evaluation to guide appropriate management.
View Article and Find Full Text PDFNat Rev Mol Cell Biol
November 2024
The Salk Institute for Biological Studies, La Jolla, CA, USA.
Telomeres protect the ends of chromosomes but shorten following cell division in the absence of telomerase activity. When telomeres become critically short or damaged, a DNA damage response is activated. Telomeres then become dysfunctional and trigger cellular senescence or death.
View Article and Find Full Text PDFSSM Qual Res Health
December 2024
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Background: Medical uncertainty may cause distress and challenge medical decision-making for patients with rare diseases and their caregivers. Few studies have examined the experience and management of medical uncertainty in rare disease and the dynamics of multiple medical uncertainty sources, issues, and management strategies.
Objective: We explored the experience and management of uncertainty in individuals with telomere biology disorders (TBDs), a set of rare cancer-prone bone marrow failure syndromes, and their caregivers.
Exp Hematol
November 2024
Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN. Electronic address:
Induced pluripotent stem cells (iPSCs) have emerged as powerful tools for in vitro modeling of bone marrow failure (BMF) syndromes and hereditary conditions predisposing to myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). This review synthesizes recent advances in iPSC-based disease modeling for various inherited BMF/MDS disorders, including Fanconi anemia, dyskeratosis congenita, Diamond Blackfan anemia syndrome, Shwachman-Diamond syndrome, and severe congenital neutropenia as well as GATA2, RUNX1, ETV6, ANKRD26, SAMD9, SAMD9L, and ADH5/ALDH2 syndromes. Although the majority of these iPSC lines are derived from patient cells, some are generated by introducing patient-specific mutations into healthy iPSC backgrounds, offering complementary approaches to disease modeling.
View Article and Find Full Text PDFTransfus Med Hemother
October 2024
Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Hum Immunol
November 2024
Department of Allergy, Asthma and Inflammation, 1st Pediatric Clinic University of Athens, Childrens' Hospital 'Agia Sophia', Athens, Greece. Electronic address:
Pediatr Dermatol
September 2024
Department of Dermatology, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Am J Med Genet A
September 2024
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA.
PLoS One
September 2024
Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh.
Surg Case Rep
September 2024
Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.
Pediatr Dermatol
September 2024
Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA.
EMBO Mol Med
October 2024
Centro de Investigaciones Energéticas Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIEMAT/CIBERER), Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD UAM), Madrid, Spain.
Telomeres are supramolecular structures that allow the DNA strand to fold back on itself and protect the linear chromosome end from being sensed as a double-strand DNA break. Telomeric conservation relies on mechanisms that replace terminal DNA sequences, and ensuring structural integrity. Telomere biology disorders (TBDs) are a heterogeneous group of low-prevalence pathologies defined by germline mutations in genes involved in telomere maintenance mechanisms (TMMs).
View Article and Find Full Text PDFEMBO Mol Med
October 2024
Centre for Genomics and Child Health, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, Newark Street, London, E12AT, UK.
Postgrad Med J
November 2024
Department of Pediatric Hematology-Oncology & Autologous Hematopoietic Stem Cell Transplantation Unit, University Hospital of Heraklion & Laboratory of Blood Diseases and Childhood Cancer Biology, School of Medicine, University of Crete, Voutes, Heraklion, Crete, 71500, Greece.
Case Rep Ophthalmol
July 2024
Department of Ophthalmology, Sanmenxia Eye Hospital/Sanmenxia Central Hospital Affiliated to Henan University of Science and Technology, Sanmenxia, China.
Clin Exp Dermatol
August 2024
Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, India.
Dermatol Pract Concept
July 2024
Department of Dermatology, Medical School, University of São Paulo, São Paulo, Brazil.
Haematologica
December 2024
Department of Metabolism, Digestion and Reproduction, Imperial College London, Burlington Danes Building, Du Cane Road, London.
Clin Exp Dermatol
August 2024
Department of Dermatology, The Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia.
J Oral Pathol Med
September 2024
Melbourne Dental School, Faculty of Medicine, Dentistry & Health Sciences, University of Melbourne, Parkville, Victoria, Australia.
J Pediatr Genet
September 2024
Pediatric Hematology and Oncology Department, School of Medicine, Istanbul Medipol University, Istanbul, Türkiye.
J Fr Ophtalmol
October 2024
Internal Medicine Service, Joan XXIII University Hospital, carrer del Dr. Mallafrè Guasch, 4, 43005 Tarragona, Spain.